HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Gumarontinib

HCID 117797905
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1642581-63-2
Standard SMILES
Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6cnn(C)c6)cn45)c3c2)cn1
InChIKey
RYBLECYFLJXEJX-UHFFFAOYSA-N
Molecular formula
C21H17N9O2S
Average molar mass
459.495 g/mol
Monoisotopic mass
459.12259178

Names & identifiers

Preferred name
Gumarontinib
English name
Glumetinib
Molecular formula
C21H17N9O2S
Molecular weight
459.48

Names & synonyms

SCC244GlumetinibGumarontinibGLUMETINIB (SCC244)Fenbuconazole Impurity 1Glumetinib, 10 mM in DMSO6-(1-Methyl-1H-pyrazol-4-yl)-1-((6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl)sulfonyl)-1H-pyrazolo[4,3-b]pyridine1H-Pyrazolo[4,3-b]pyridine, 6-(1-methyl-1H-pyrazol-4-yl)-1-[[6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]sulfonyl]-SCC 244,proliferation,tumor,cancer,Glumetinib,bioavailable,oral,HCC,SCC-244,inhibit,c-Met/HGFR,ATP-competitive,cell,NSCLC,Inhibitor

Database identifiers

CAS
1642581-63-2
PubChem CID
117797905
DTXSID
DTXSID601375585
ChEMBL
CHEMBL4594400
UNII
7JTT036WGX
Nikkaji
J3.769.202F

Properties

Physicochemical properties

Density
1.61 · 1.61±0.1 g/cm3(Predicted)
storage temp.
-20 °C · -20°C
solubility
Soluble in DMSO (>25 mg/ml)
form
solid
pka
0.09 · 0.09±0.10(Predicted)
color
Beige
Stability
1 year · Stable for 1 year as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
FDA UNII
7 JTT036WGX · 7JTT036WGX
NCI Drug Dictionary
glumetinib
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338

Chemistry & industry

Applications · 2 items

DescriptionGlumetinib (1642581-63-2) is a highly selective (2400-fold selectivity against a panel of 312 kinases) and potent (IC50 = 0.42 nM) inhibitor of c-Met kinase. It induced tumor regression in MET-driven CDX (MKN-45, SNU-5, EBC-1) and PDX (4 NSCLC, 5 HCC) tumor models.

UsesGlumetinib (SCC244) is a highly selective, orally bioavailable, ATP-competitive c-Met inhibitor with an IC50 of 0.42 nM. Glumetinib has greater than 2400-fold selectivity for c-Met over those 312 kinases evaluated, including the c-Met family member RON and highly homologous kinases Axl, Mer, TyrO3. Antitumor activity[1].

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes